Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Headache|January 5, 2023
A qualitative evidence synthesis of patient perspectives on migraine treatment features and outcomesMeritxell Urtecho, Brittin Wagner, Zhen Wang, et al.
The Neurologist|September 13, 2007
Caffeine for the prevention and treatment of postdural puncture headache: debunking the mythRashmi B Halker, Bart M Demaerschalk, Kay E Wellik, et al.
The Journal of Headache and Pain|April 26, 2022
Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trialsRichard B Lipton, Rashmi B Halker Singh, Dennis A Revicki, et al.
Headache|November 12, 2020
Reversion From Chronic Migraine to Episodic Migraine in Patients Treated With Fremanezumab: Post Hoc Analysis From HALO CM StudyRichard B Lipton, Joshua M Cohen, Kristen Bibeau, et al.
Cephalalgia : an International Journal of Headache|November 19, 2024
Benefit-risk assessment based on number needed to treat and number needed to harm: Atogepant vs. calcitonin gene-related peptide monoclonal antibodiesJessica Ailani, Anjana Lalla, Rashmi B Halker Singh, et al.
Neurology|September 29, 2022
Incidence of Status Migrainosus in Olmsted County, Minnesota, United States: Characterization and Predictors of RecurrenceJuliana H VanderPluym, Kartik Mangipudi, Amir Abdallah Mbonde, et al.
The Neurologist|September 2, 2011
Risk of development of medication overuse headache with nonsteroidal anti-inflammatory drug therapy for migraine: a critically appraised topicAmaal J Starling, Charlene Hoffman-Snyder, Rashmi B Halker, et al.
Cephalalgia : an International Journal of Headache|August 28, 2023
Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trialRichard B Lipton, Rashmi B Halker Singh, Laszlo Mechtler, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 24, 2013
Canadian Headache Society Guideline: acute drug therapy for migraine headacheIrene Worthington, Tamara Pringsheim, Marek J Gawel, et al.
Cephalalgia : an International Journal of Headache|August 31, 2023
Harassment in the headache field: a global web-based cross-sectional surveyIrene de Boer, Anna Ambrosini, Rashmi B Halker Singh, et al.
Pageof 6